Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
101.68
-2.56 (-2.46%)
At close: Nov 13, 2024, 4:00 PM
102.09
+0.41 (0.40%)
After-hours: Nov 13, 2024, 4:00 PM EST
Merit Medical Systems Revenue
Merit Medical Systems had revenue of $339.85M in the quarter ending September 30, 2024, with 7.81% growth. This brings the company's revenue in the last twelve months to $1.33B, up 8.12% year-over-year. In the year 2023, Merit Medical Systems had annual revenue of $1.26B with 9.24% growth.
Revenue (ttm)
$1.33B
Revenue Growth
+8.12%
P/S Ratio
4.45
Revenue / Employee
$190,773
Employees
6,950
Market Cap
5.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.26B | 106.39M | 9.24% |
| Dec 31, 2022 | 1.15B | 76.23M | 7.09% |
| Dec 31, 2021 | 1.07B | 110.88M | 11.50% |
| Dec 31, 2020 | 963.88M | -30.98M | -3.11% |
| Dec 31, 2019 | 994.85M | 112.10M | 12.70% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| R1 RCM | 2.46B |
| RadNet | 1.77B |
| Lantheus Holdings | 1.50B |
| Ionis Pharmaceuticals | 803.07M |
| Inspire Medical Systems | 755.59M |
| Corcept Therapeutics | 628.56M |
| Blueprint Medicines | 434.42M |
| Cytokinetics | 3.22M |
MMSI News
- 12 days ago - Merit Medical Completes Acquisition of Lead Management Portfolio from Cook Medical - GlobeNewsWire
- 13 days ago - Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024 - GlobeNewsWire
- 2 months ago - Merit Medical Signs Agreement to Purchase Lead Management Portfolio from Cook Medical - GlobeNewsWire
- 2 months ago - Merit Medical's WRAPSODY WAVE Trial Demonstrates Superior Patency versus Standard of Care in AV Fistula Patients - GlobeNewsWire
- 2 months ago - Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress - GlobeNewsWire
- 3 months ago - Merit Medical Systems, Inc. (MMSI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Merit Medical Reports Second Quarter 2024 Results and Raises Full-Year Guidance - GlobeNewsWire